Analytics

Find out how analytics, from data mining to cognitive computing, is changing the way we do business

Analytics | Machine Learning
Charlie Chase 0
How life science and health care supply chains can adapt to disruption

Robert Handfield, PhD, is a distinguished professor of Supply Chain Management at North Carolina State University and Director of the Supply Chain Resource Cooperative. In an episode of the Health Pulse Podcast, Handfield gave his views regarding the challenges health care and life science companies have encountered over the past two years

Analytics
Zeynep Tunc 2
5 steps to build agile and resilient collections

High unemployment rates of the post-pandemic era in many recovering regions and increasing inflation rates are signaling an economic recession. With the pressure of increasing energy prices on consumer cash flow and households in many advanced economies facing a cost of living crisis, collections managers know it’s time to transform

Analytics | Artificial Intelligence | Machine Learning
Christian Hardahl 0
Delivering the future: how biomarkers and analytics in maternity care save lives

Becoming a parent is one of the most exciting things in life. Unfortunately, sometimes pregnancy complications occur, remaining a serious challenge, that is not often talked about. Ahead are interviews with leading researchers in Dublin aimed to understand the impact of data and analytics on maternal health. According to the

Analytics | Customer Intelligence | Data Visualization | Marketing
Charlie Chase 0
How CDP technologies offer sales and marketing teams powerful insights

In today's environment, data is exceedingly important but also increasingly harder to get and manage. A reliable customer data platform (CDP) can provide significant value to retail and consumer packaged goods (CPG) companies. Customer data platforms are used to consolidate and integrate customer and consumer data into a single data source. CDP

Advanced Analytics | Analytics
Soundarya Palanisamy 0
Decentralizing clinical trials: how COVID-19 has changed drug development

The COVID-19 pandemic brought an enormous urgency to the life sciences sector. Companies vied for suitable treatments and in less than a year, COVID-19 vaccines were developed. This demonstrated clearly that the sector could move at speed when necessary. Though vaccines were supported by regulators, inefficiencies in vaccine and drug development were exposed.

1 21 22 23 24 25 86

Back to Top